Shopping Cart
- Remove All
- Your shopping cart is currently empty
LQZ-7F is a small molecule survivin dimerisation inhibitor with anticancer activity.LQZ-7F induces proteasome-dependent survivin degradation, mitotic arrest, and apoptosis, and blocks human tumour growth in mouse xenograft assays.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $483 | In Stock | |
10 mg | $692 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,490 | In Stock | |
100 mg | $1,970 | In Stock | |
500 mg | $3,930 | In Stock |
Description | LQZ-7F is a small molecule survivin dimerisation inhibitor with anticancer activity.LQZ-7F induces proteasome-dependent survivin degradation, mitotic arrest, and apoptosis, and blocks human tumour growth in mouse xenograft assays. |
In vitro | LQZ-7F and LQZ-7F1 treatment at 2.5 μM for 72 hours inhibited the viability of prostate cancer cell lines PC-3 and C4-2, as determined by MTT assay. |
In vivo | LQZ-7F was administered at 25 mg/kg via intraperitoneal injection once every 3 days for a total of 8 treatments. On the 30th day after treatment, it was found to inhibit the growth of xenograft tumors[1]. |
Molecular Weight | 349.26 |
Formula | C14H7N9O3 |
Cas No. | 354543-09-2 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
Solubility Information | DMSO: 2 mg/mL (5.73 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.